Quality of life assessment in cancer patients receiving single-agent versus multidrug chemotherapy protocols

Quality of life (QoL) is an essential factor in therapeutic decision-making for human patients and is commonly used as an endpoint in clinical trials of cancer treatments. To compare owners' perception of QoL in canine and feline patients affected by different tumor histotypes treated with sing...

Full description

Saved in:
Bibliographic Details
Published in:Open veterinary journal (Tripoli, Libya) Libya), 2021-01, Vol.11 (4), p.755-763
Main Authors: Bianchi, Marco Luigi, Drudi, Dario, Treggiari, Elisabetta, Catalucci, Chiara, Attorri, Valeria, Bonazzi, Irene, Valenti, Paola
Format: Article
Language:English
Subjects:
Animals
canine
Cat Diseases - drug therapy
Cats
chemotherapy
Dog Diseases - drug therapy
Dogs
feline
Humans
Neoplasms - drug therapy
Neoplasms - veterinary
Original Research
Ownership
Prospective Studies
Quality of Life
tumor
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Quality of life (QoL) is an essential factor in therapeutic decision-making for human patients and is commonly used as an endpoint in clinical trials of cancer treatments. To compare owners' perception of QoL in canine and feline patients affected by different tumor histotypes treated with single-agent or multidrug protocols. Owners were asked to assess the impact on QoL of their pets undergoing chemotherapy treatment by answering a questionnaire and assigning a score to different health-related parameters reported to affect QoL. Questionnaires of 101 patients (85 dogs and 16 cats), collected at different time points, were analyzed. Fifty-seven patients were given single-agent chemotherapy (carboplatin, doxorubicin, lomustine, melphalan, mitoxantrone, vinblastine, and vinorelbine), whereas 44 were given multiple-agent treatment. When diverse factors including chemotherapy treatment type (single-agent multidrug regimens) and the onset and kind of adverse effects were considered, no significant variations in owners' perceptions of their pets' QoL were discovered. Chemotherapy type (single-agent multidrug protocol) and related adverse events are shown, which did not influence owners' perception of their pet's QoL.Future prospective studies should look into clinical characteristics that might affect QoL, such as the patient's age, tumor stage, and protocol purpose (curative palliative).
ISSN:2226-4485
2218-6050
DOI:10.5455/OVJ.2021.v11.i4.28